These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Cetković A, Miljic D, Ljubić A, Patterson M, Ghatei M, Stamenković J, Nikolic-Djurovic M, Pekic S, Doknic M, Glišić A, Bloom S, Popovic V. Endocr Res; 2012; 37(2):78-88. PubMed ID: 22489921 [Abstract] [Full Text] [Related]
7. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Boutin A, Guerby P, Gasse C, Tapp S, Bujold E. Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265 [Abstract] [Full Text] [Related]
8. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes. Dieber-Rotheneder M, Beganovic S, Desoye G, Lang U, Cervar-Zivkovic M. Life Sci; 2012 Oct 15; 91(13-14):710-5. PubMed ID: 22580289 [Abstract] [Full Text] [Related]
10. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Odibo AO, Zhong Y, Longtine M, Tuuli M, Odibo L, Cahill AG, Macones GA, Nelson DM. Placenta; 2011 Apr 15; 32(4):333-8. PubMed ID: 21324404 [Abstract] [Full Text] [Related]
15. Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study. Anzoategui S, Gibbone E, Wright A, Nicolaides KH, Charakida M. Ultrasound Obstet Gynecol; 2022 Aug 15; 60(2):207-214. PubMed ID: 35502146 [Abstract] [Full Text] [Related]